TRVN logo

TRVN
Trevena Inc

23,989
Mkt Cap
$9,588.00
Volume
39.00
52W High
$1.93
52W Low
$0.001
Price
$0.0111
TRVN Fundamentals
Prev Close
$0.0111
Open
$0.0111
50D MA
$0.0115
Beta
-11.61
Avg. Volume
1,316.73
Loading...
Loading...
Trevena, Inc. is a biopharmaceutical company, which focuses on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. The company was founded by Maxine Gowen, Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin, and Erin Whalen on November 9, 2007 and is headquartered in Atlanta, GA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Trevena Inc?
What is the 52-week high for Trevena Inc?
What is the 52-week low for Trevena Inc?
What is Trevena Inc stock price today?
What was Trevena Inc stock price yesterday?
What is the 50-day moving average of Trevena Inc?

Latest TRVN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.